About Max
This author has not written his bio yet.
But we are proud to say that Max contributed 390 entries already.
Entries by Max
Newsletter 3
/0 Comments/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Here I am with the third newsletter from the site. I have a hope: this week I found little new information about ongoing or starting clinical trials. I have a feeling that this might be because the “breaking news,” especially those that […]
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
225Ac abiraterone acetate ADC AI ai in healthcare antibody-drug conjugate apalutamide ASCO 2025 ATM bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy CAR-T clinical trial clinical trials crispr CYP11A1 inhibitor darolutamide drug repurposing drug resistance enzalutamide HRR immune checkpoint inhibitors immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA MYC NEPC neuroendocrine prostate cancer olaparib oncolytic virus personalized medicine Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data theranostics
Latest Posts
- Alpha DaRT: A Promising Frontier in the Treatment of Prostate, Bladder, and Advanced Cancers August 22, 2025
- Statins Linked to Improved Survival in Advanced Prostate Cancer Patients on Apalutamide August 22, 2025
- OMNIRAY: a Phase 1 Clinical Trial for LY4257496 for mCRPC August 20, 2025
- Nutrition and Inflamation: New Research Unveils Five Universal Patient Clusters in Oncology August 19, 2025